Literature DB >> 26673092

The interfacial properties of the peptide Polybia-MP1 and its interaction with DPPC are modulated by lateral electrostatic attractions.

Dayane S Alvares1, Maria Laura Fanani2, João Ruggiero Neto3, Natalia Wilke4.   

Abstract

Polybia-MP1 (IDWKKLLDAAKQIL-NH2), extracted from the Brazilian wasp Polybia paulista, exhibits a broad-spectrum bactericidal activity without being hemolytic and cytotoxic. In the present study, we analyzed the surface properties of the peptide and its interaction with DPPC in Langmuir monolayers. Polybia-MP1 formed stable monolayers, with lateral areas and surface potential values suggesting a mostly α-helical structure oriented near perpendicular to the membrane plane. In DPPC-peptide mixed monolayers, MP1 co-crystallized with the lipid forming branched domains only when the subphase was pure water. On subphases with high salt concentrations or at acidic or basic conditions, the peptide formed less densely packed films and was excluded from the domains, indicating the presence of attractive electrostatic interactions between peptides, which allow them to get closer to each other and to interact with DPPC probably as a consequence of a particular peptide arrangement. The residues responsible of the peptide-peptide attraction are suggested to be the anionic aspartic acids and the cationic lysines, which form a salt bridge, leading to oriented interactions in the crystal and thereby to branched domains. For this peptide, the balance between total attractive and repulsive interactions may be finely tuned by the aqueous ionic strength and pH, and since this effect is related with lysines and aspartic acids, similar effects may also occur in other peptides containing these residues in their sequences.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Domain shape; Langmuir-monolayer; Lipid–peptide co-crystals; Membrane electrostatic interactions; Peptide–peptide lateral interactions

Mesh:

Substances:

Year:  2015        PMID: 26673092     DOI: 10.1016/j.bbamem.2015.12.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Lipid-packing perturbation of model membranes by pH-responsive antimicrobial peptides.

Authors:  Dayane S Alvares; Taisa Giordano Viegas; João Ruggiero Neto
Journal:  Biophys Rev       Date:  2017-08-29

2.  Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action.

Authors:  Annielle Mendes Brito da Silva; Laíz Costa Silva-Gonçalves; Fernando Augusto Oliveira; Manoel Arcisio-Miranda
Journal:  Mol Neurobiol       Date:  2017-09-30       Impact factor: 5.590

3.  Interaction mechanism of three egg protein derived ACE inhibitory tri-peptides and DPPC membrane using FS, FTIR, and DSC studies.

Authors:  Huizhuo Ji; Wenzhu Zhao; Zhipeng Yu
Journal:  Food Chem X       Date:  2022-06-15

Review 4.  Biophysical approaches for exploring lipopeptide-lipid interactions.

Authors:  Sathishkumar Munusamy; Renaud Conde; Brandt Bertrand; Carlos Munoz-Garay
Journal:  Biochimie       Date:  2020-01-21       Impact factor: 4.079

5.  The Spectrum of Design Solutions for Improving the Activity-Selectivity Product of Peptide Antibiotics against Multidrug-Resistant Bacteria and Prostate Cancer PC-3 Cells.

Authors:  Davor Juretić; Anja Golemac; Denise E Strand; Keshi Chung; Nada Ilić; Ivana Goić-Barišić; François-Xavier Pellay
Journal:  Molecules       Date:  2020-08-01       Impact factor: 4.411

6.  Multiple roles of ribosomal antimicrobial peptides in tackling global antimicrobial resistance.

Authors:  Huy Xuan Luong; Hoa Doan Ngan; Hai Bui Thi Phuong; Thang Nguyen Quoc; Truong Thanh Tung
Journal:  R Soc Open Sci       Date:  2022-01-26       Impact factor: 2.963

Review 7.  Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics.

Authors:  Plinio A Trinidad-Calderón; Carlos Daniel Varela-Chinchilla; Silverio García-Lara
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.